Provided by Tiger Fintech (Singapore) Pte. Ltd.

Relay Therapeutics

6.62
+0.33005.25%
Post-market: 6.790.1700+2.57%17:32 EST
Volume:1.68M
Turnover:11.16M
Market Cap:1.15B
PE:-3.78
High:6.79
Open:6.26
Low:6.17
Close:6.29
52wk High:7.64
52wk Low:1.78
Shares:173.32M
Float Shares:102.63M
Volume Ratio:0.67
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7494
EPS(LYR):-2.3638
ROE:-41.14%
ROA:-25.37%
PB:1.89
PE(LYR):-2.80

Loading ...

Relay Therapeutics (RLAY): A Fresh Board and Narrower Losses—What Does It Mean for Valuation?

Simply Wall St.
·
Yesterday

Do New Board Appointments Signal a Strategic Shift for Relay Therapeutics (RLAY) as Cash Outlook Improves?

Simply Wall St.
·
Nov 11

Stock Track | Relay Therapeutics Plummets 7.81% in Pre-market Following Q3 Earnings Miss and Wider Net Loss

Stock Track
·
Nov 07

Bank of America Securities Sticks to Its Buy Rating for Relay Therapeutics (RLAY)

TIPRANKS
·
Nov 07

Stock Track | Relay Therapeutics Plunges Nearly 6% After Q3 Earnings Miss and Higher Net Loss

Stock Track
·
Nov 07

Relay Therapeutics slightly misses Q3 net loss estimates, expects cash reserves to fund operations into 2029

Reuters
·
Nov 07

Relay Therapeutics Expands Board with New Appointments

TIPRANKS
·
Nov 07

Relay Therapeutics Inc. Files Initial Beneficial Ownership Statement for Director Lonnel Coats

Reuters
·
Nov 07

Relay Therapeutics Files Initial Beneficial Ownership Statement for Director Habib J. Dable

Reuters
·
Nov 07

Relay Therapeutics Q3 EPS $(0.43) Misses $(0.42) Estimate

Benzinga
·
Nov 07

Relay Therapeutics Q3 Net Income USD -74.149 Million Vs. IBES Estimate USD -73.9 Million

Reuters
·
Nov 07

Relay Therapeutics Q3 Operating Expenses USD 80.391 Million

THOMSON REUTERS
·
Nov 07

Top Executive Makes Significant Stock Sale at Relay Therapeutics

TIPRANKS
·
Nov 05

Top Executives at Relay Therapeutics Cash In on Major Stock Sales!

TIPRANKS
·
Oct 31

Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025

GlobeNewswire
·
Oct 31

Barfresh Food Group Among 3 Promising Penny Stocks

Simply Wall St.
·
Sep 19

Relay Therapeutics Coverage Assumed by Guggenheim at Buy

Dow Jones
·
Sep 04

Relay Therapeutics Inc. to Participate in Wells Fargo Healthcare and Morgan Stanley Global Conferences

Reuters
·
Aug 29

HC Wainwright Adjusts Price Target on Relay Therapeutics to $14 From $16, Maintains Buy Rating

MT Newswires Live
·
Aug 26

Relay Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 26